Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. MMED
6. CRDO
7. NVDA
8. GPUS
9. SGLD
10. AVEX

Go back to Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
(NASDAQ: RNTX) Delayed: 0.75 --0 (-0%)
Previous Close $0.75    52 Week High $ 
Open $0.75    52 Week Low $ 
Day High $0.75    P/E N/A 
Day Low $0.75    EPS $ 
Volume 3,595